Diacylglycerol Lipase, alpha (DAGLA) (C-Term) Peptide
Aperçu rapide pour Diacylglycerol Lipase, alpha (DAGLA) (C-Term) Peptide (ABIN8098853)
Antigène
Origine
Source
Application
-
-
Protein Region
- C-Term
-
Fonction
- DAGLA Peptide - C-terminal region
-
Séquence
- YQPAKPTPLP RKRSEASPHE NTNHKSPHKN SISLKEQEES LGSPVHHSPF
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti- DAGLA Antibody (ARP82739_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- DAGLA (Diacylglycerol Lipase, alpha (DAGLA))
-
Sujet
-
Background Information: This gene encodes a diacylglycerol lipase. The encoded enzyme is involved in the biosynthesis of the endocannabinoid 2-arachidonoyl-glycerol.
Alternative Symbols: NSDDR, C11orf11, DAGLALPHA, DAGL(ALPHA)
-
Poids moléculaire
- 114 kDa
-
ID gène
- 747
-
NCBI Accession
- NP_006124
-
UniProt
- Q9Y4D2
Antigène
-